{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T04:05:48Z","timestamp":1748664348479,"version":"3.41.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:00:00Z","timestamp":1748563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-025-03490-y","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T06:03:50Z","timestamp":1748585030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expression level and clinical significance of IL-29 in serum of patients with coronary heart disease"],"prefix":"10.1186","volume":"20","author":[{"given":"Ping","family":"Ni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yicheng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,30]]},"reference":[{"issue":"4","key":"3490_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.tcm.2021.04.002","volume":"32","author":"GE Shaya","year":"2022","unstructured":"Shaya GE, Leucker TM, Jones SR, Martin SS, Toth PP. Coronary heart disease risk: Low-density lipoprotein and beyond. Trends Cardiovasc Med. 2022;32(4):181\u201394.","journal-title":"Trends Cardiovasc Med"},{"issue":"11","key":"3490_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11886-017-0919-x","volume":"19","author":"PH Wirtz","year":"2017","unstructured":"Wirtz PH, von Kanel R. Psychological stress, inflammation, and coronary heart disease. Curr Cardiol Rep. 2017;19(11):111.","journal-title":"Curr Cardiol Rep"},{"key":"3490_CR3","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.yjmcc.2019.09.001","volume":"136","author":"Y Dong","year":"2019","unstructured":"Dong Y, Chen H, Gao J, Liu Y, Li J, Wang J. Molecular machinery and interplay of apoptosis and autophagy in coronary heart disease. J Mol Cell Cardiol. 2019;136:27\u201341.","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"3490_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.31887\/DCNS.2018.20.1\/mdehert","volume":"20","author":"M De Hert","year":"2018","unstructured":"De Hert M, Detraux J, Vancampfort D. The intriguing relationship between coronary heart disease and mental disorders. Dialogues Clin Neurosci. 2018;20(1):31\u201340.","journal-title":"Dialogues Clin Neurosci"},{"issue":"8","key":"3490_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1080\/13543776.2018.1503650","volume":"28","author":"L Zhang","year":"2018","unstructured":"Zhang L, Zhang Y, Zhao Y, Wang Y, Ding H, Xue S, et al. Circulating MiRNAs as biomarkers for early diagnosis of coronary artery disease. Expert Opin Ther Pat. 2018;28(8):591\u2013601.","journal-title":"Expert Opin Ther Pat"},{"key":"3490_CR6","doi-asserted-by":"crossref","unstructured":"de Oliveira Laterza Ribeiro M, Correia VM, Herling de Oliveira LL, Soares PR, Scudeler TL. Evolving diagnostic and management advances in coronary heart disease. Life (Basel). 2023;13(4).","DOI":"10.3390\/life13040951"},{"key":"3490_CR7","doi-asserted-by":"crossref","unstructured":"Medina-Leyte DJ, Zepeda-Garcia O, Dominguez-Perez M, Gonzalez-Garrido A, Villarreal-Molina T, Jacobo-Albavera L. Endothelial dysfunction, inflammation and coronary artery disease: potential biomarkers and promising therapeutical approaches. Int J Mol Sci. 2021;22(8).","DOI":"10.3390\/ijms22083850"},{"key":"3490_CR8","doi-asserted-by":"publisher","first-page":"107475","DOI":"10.1016\/j.intimp.2021.107475","volume":"94","author":"S Xu","year":"2021","unstructured":"Xu S, Zhang J, Liu J, Ye J, Xu Y, Wang Z, et al. The role of interleukin-10 family members in cardiovascular diseases. Int Immunopharmacol. 2021;94:107475.","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"3490_CR9","doi-asserted-by":"publisher","first-page":"7926","DOI":"10.1111\/jcmm.14697","volume":"23","author":"JM Wang","year":"2019","unstructured":"Wang JM, Huang AF, Xu WD, Su LC. Insights into IL-29: emerging role in inflammatory autoimmune diseases. J Cell Mol Med. 2019;23(12):7926\u201332.","journal-title":"J Cell Mol Med"},{"key":"3490_CR10","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.imlet.2020.01.004","volume":"220","author":"LF da Rocha Junior","year":"2020","unstructured":"da Rocha Junior LF, Branco Pinto Duarte AL, de Melo Rego MJB, de Almeida AR, de Melo Vilar K, de Lima HD, et al. Sensitivity and specificity of Interleukin 29 in patients with rheumatoid arthritis and other rheumatic diseases. Immunol Lett. 2020;220:38\u201343.","journal-title":"Immunol Lett"},{"issue":"4","key":"3490_CR11","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.abd.2020.11.007","volume":"96","author":"LX Fu","year":"2021","unstructured":"Fu LX, Chen T, Guo ZP, Cao N, Zhang LW, Zhou PM. Enhanced serum interferon-lambda 1 interleukin-29 levels in patients with psoriasis vulgaris. Bras Dermatol. 2021;96(4):416\u201321.","journal-title":"Bras Dermatol"},{"issue":"1","key":"3490_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/sj.gene.6364348","volume":"8","author":"WJ Jordan","year":"2007","unstructured":"Jordan WJ, Eskdale J, Boniotto M, Rodia M, Kellner D, Gallagher G. Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda1\/IL-29). Genes Immun. 2007;8(1):13\u201320.","journal-title":"Genes Immun"},{"issue":"1","key":"3490_CR13","doi-asserted-by":"publisher","first-page":"e027222","DOI":"10.1161\/JAHA.122.027222","volume":"12","author":"N Hao","year":"2023","unstructured":"Hao N, Zhou Z, Zhang F, Li Y, Hu R, Zou J, et al. Interleukin-29 accelerates vascular calcification via JAK2\/STAT3\/BMP2 signaling. J Am Heart Assoc. 2023;12(1):e027222.","journal-title":"J Am Heart Assoc"},{"key":"3490_CR14","doi-asserted-by":"crossref","unstructured":"Chepeleva EV. Cell therapy in the treatment of coronary heart disease. Int J Mol Sci. 2023;24(23).","DOI":"10.3390\/ijms242316844"},{"key":"3490_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.actbio.2023.09.011","volume":"171","author":"J Guo","year":"2023","unstructured":"Guo J, Wang H, Li Y, Zhu S, Hu H, Gu Z. Nanotechnology in coronary heart disease. Acta Biomater. 2023;171:37\u201367.","journal-title":"Acta Biomater"},{"issue":"4","key":"3490_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1001\/jamacardio.2020.7073","volume":"6","author":"SB Dugani","year":"2021","unstructured":"Dugani SB, Moorthy MV, Li C, Demler OV, Alsheikh-Ali AA, Ridker PM, et al. Association of lipid, inflammatory, and metabolic biomarkers with age at onset for incident coronary heart disease in women. JAMA Cardiol. 2021;6(4):437\u201347.","journal-title":"JAMA Cardiol"},{"issue":"1","key":"3490_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12944-023-01856-6","volume":"22","author":"DL Pontzen","year":"2023","unstructured":"Pontzen DL, Bahls M, Albrecht D, Felix SB, Dorr M, Ittermann T, et al. Low-grade inflammation is associated with a heterogeneous lipoprotein subclass profile in an apparently healthy population sample. Lipids Health Dis. 2023;22(1):100.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3490_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000430330","volume":"37","author":"D Xu","year":"2015","unstructured":"Xu D, Yan S, Wang H, Gu B, Sun K, Yang X, et al. IL-29 enhances LPS\/TLR4-Mediated inflammation in rheumatoid arthritis. Cell Physiol Biochem. 2015;37(1):27\u201334.","journal-title":"Cell Physiol Biochem"},{"key":"3490_CR19","doi-asserted-by":"crossref","unstructured":"He J, Huang M, Li N, Zha L, Yuan J. Genetic association and potential mediators between sarcopenia and coronary heart disease: A bidirectional Two-Sample, Two-Step Mendelian randomization study. Nutrients. 2023;15(13).","DOI":"10.3390\/nu15133013"},{"issue":"11","key":"3490_CR20","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1016\/j.hlc.2023.07.010","volume":"32","author":"A Khoja","year":"2023","unstructured":"Khoja A, Andraweera PH, Lassi ZS, Ali A, Zheng M, Pathirana MM, et al. Risk factors for Early-Onset versus Late-Onset coronary heart disease (CHD): systematic review and Meta-Analysis. Heart Lung Circ. 2023;32(11):1277\u2013311.","journal-title":"Heart Lung Circ"},{"key":"3490_CR21","doi-asserted-by":"crossref","unstructured":"Wu H, Chiou J. Potential benefits of probiotics and prebiotics for coronary heart disease and stroke. Nutrients. 2021;13(8).","DOI":"10.3390\/nu13082878"},{"issue":"9709","key":"3490_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","volume":"375","author":"C Emerging Risk Factors","year":"2010","unstructured":"Emerging Risk Factors C, Kaptoge S, Di Angelantonio E, Lowe G, Pepys MB, Thompson SG, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132\u201340.","journal-title":"Lancet"},{"key":"3490_CR23","doi-asserted-by":"publisher","first-page":"704501","DOI":"10.3389\/fcvm.2021.704501","volume":"8","author":"X Zhao","year":"2021","unstructured":"Zhao X, Xu J, Tang X, Huang K, Li J, Liu R, et al. Effect of NPC1L1 and HMGCR genetic variants with premature Triple-Vessel coronary disease. Front Cardiovasc Med. 2021;8:704501.","journal-title":"Front Cardiovasc Med"},{"issue":"22","key":"3490_CR24","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.21037\/atm-22-5279","volume":"10","author":"S Huang","year":"2022","unstructured":"Huang S, Wang L, Li J, Ma L, He X, Zhang Q, et al. Oxygen pulse variation in symptomatic patients with suspected coronary artery disease: a diagnostic analysis. Ann Transl Med. 2022;10(22):1225.","journal-title":"Ann Transl Med"},{"key":"3490_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.clinbiochem.2020.08.005","volume":"85","author":"C Chang","year":"2020","unstructured":"Chang C, Pan Y, Du H, Wang X, Li X. Serum amyloid A1 can be a novel biomarker for evaluating the presence and severity of acute coronary syndrome. Clin Biochem. 2020;85:27\u201332.","journal-title":"Clin Biochem"},{"issue":"3","key":"3490_CR26","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00392-019-01511-0","volume":"109","author":"A Peikert","year":"2020","unstructured":"Peikert A, Kaier K, Merz J, Manhart L, Schafer I, Hilgendorf I, et al. Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohort. Clin Res Cardiol. 2020;109(3):315\u201323.","journal-title":"Clin Res Cardiol"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-025-03490-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-025-03490-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-025-03490-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T06:03:54Z","timestamp":1748585034000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-025-03490-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,30]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3490"],"URL":"https:\/\/doi.org\/10.1186\/s13019-025-03490-y","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,30]]},"assertion":[{"value":"20 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of The Third People\u2019s Hospital of Kunshan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"249"}}